ISPC
iSpecimen Inc
NASDAQ: ISPC · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.23
+22.48% today
Updated 2026-04-30
Market cap
$91280.00
P/E ratio
—
P/S ratio
0.05x
EPS (TTM)
$-91.20
Dividend yield
—
52W range
$4 – $103
Volume
34.8M
iSpecimen Inc (ISPC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.39M | $4.30M | $8.18M | $11.14M | $10.40M | $9.93M | $9.29M | $1.93M |
| Revenue growth (YoY) | — | -2.2% | +90.4% | +36.1% | -6.6% | -4.6% | -6.4% | -79.2% |
| Cost of revenue | $2.36M | $2.13M | $3.59M | $5.25M | $4.76M | $4.82M | $5.30M | $1.90M |
| Gross profit | $2.03M | $2.17M | $4.60M | $5.89M | $5.65M | $5.11M | $3.99M | $24110.00 |
| Gross margin | 46.2% | 50.5% | 56.2% | 52.9% | 54.3% | 51.4% | 42.9% | 1.2% |
| R&D | $1.21M | $993329.00 | $1.47M | $1.84M | $2.66M | $3.57M | $3.53M | $2.16M |
| SG&A | $2.19M | $2.85M | $3.26M | $6.98M | $8.93M | $7.72M | $7.70M | $3.47M |
| Operating income | $-3.36M | $-3.88M | $-2.41M | $-5.93M | $-10.19M | $-11.17M | $-12.73M | $-8.98M |
| Operating margin | -76.4% | -90.3% | -29.4% | -53.2% | -97.9% | -112.5% | -137.0% | -465.4% |
| EBITDA | $-3.79M | $-2.52M | $-1.74M | $-5.86M | $-8.80M | $-8.80M | $-12.73M | $-8.75M |
| EBITDA margin | -86.2% | -58.7% | -21.2% | -52.6% | -84.6% | -88.7% | -137.0% | -453.4% |
| EBIT | $-4.26M | $-3.16M | $-2.56M | $-6.86M | $-10.01M | $-10.87M | $-12.67M | $-10.48M |
| Interest expense | $1.21M | $1.72M | $2.10M | $2.10M | $238963.00 | $230785.00 | $220074.00 | $1949.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.35M | $-4.73M | $-4.65M | $-8.96M | $-10.25M | $-11.10M | $-12.50M | $-10.49M |
| Net income growth (YoY) | — | +11.6% | +1.6% | -92.6% | -14.3% | -8.3% | -12.6% | +16.1% |
| Profit margin | -121.7% | -110.0% | -56.8% | -80.5% | -98.5% | -111.8% | -134.5% | -543.7% |